| |
|
|
|
Matinas BioPharma Holdings Inc.  
|
|
0.6972 0.002 (0%) |
10-18 16:00 |
|
Open: |
0.7 |
Pre close: |
0.695 |
Target:
|
0.85
|
|
High: |
0.712 |
Low: |
0.6927 |
Resistance:
|
0.73
0.85
|
|
Volume: |
166,925 |
Market Cap: |
113M |
Support:
|
0.64
0.58
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.70
 |
MACD |
MACD(12,26):
|
0.01 |
|
MA(20): |
0.67 |
Signal(12,26,9): |
0.00 |
|
MA(100): |
0.75  |
Stochastic Oscillator |
%K(14,3):
|
75.45 |
|
MA(250): |
0.87 |
%D(3): |
79.39 |
|
Average Volume(K) |
3-Month: |
44148
|
52-Week |
High:
|
1.50 |
|
10-Days: |
30447 |
Low: |
0.50 |
|
RSI |
RSI(14):
|
54.57 |
Change(%): |
-22.4 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.130 |
Return on Equity (ttm) |
-52.7 |
Shares Out. (M) |
162.41 |
|
EPS Est. Current Year |
-0.290 |
Return on Assets (ttm) |
-30.6 |
Shares Float (M) |
137.61 |
|
EPS Est. Next Year |
-0.240 |
PEG Ratio |
0.00 |
% Held by Insiders |
10.40 |
|
EPS Est. Next Quarter |
-0.050 |
Qtrly Rev. Growth |
-0.0 |
% Held by Institutions |
13.41 |
|
Forward EPS |
-0.140 |
Gross Profit (p.s.) |
-0.041 |
Shares Short (K) |
5250 |
|
Book Value (p.s.) |
0.210 |
EBITDA (p.s.) |
-0.095 |
P/E |
-5.36 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.32 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-10.38 |
P/S |
0.00 |
|
Operating Margin |
-17530.69 |
Levered Free Cash Flow
(M) |
-5.38 |
P/CF |
-10.91 |
|
|
|
|
|
|
